Novozymes A/S (OTCMKTS:NVZMY) Posts Quarterly Earnings Results

Novozymes A/S (OTCMKTS:NVZMY) issued its earnings results on Thursday. The biotechnology company reported $0.48 EPS for the quarter, Zacks reports.

Novozymes A/S Price Performance

Shares of NVZMY stock traded up $4.54 on Thursday, hitting $64.00. 39,440 shares of the company’s stock were exchanged, compared to its average volume of 37,933. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.75 and a quick ratio of 1.07. Novozymes A/S has a 12 month low of $53.95 and a 12 month high of $75.99. The stock has a market cap of $29.97 billion, a P/E ratio of 37.65, a price-to-earnings-growth ratio of 1.15 and a beta of 0.96. The company has a 50 day moving average of $62.10 and a 200 day moving average of $66.28.

Novozymes A/S Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd were given a dividend of $0.1856 per share. This represents a dividend yield of 88.0%. The ex-dividend date was Tuesday, September 2nd. Novozymes A/S’s dividend payout ratio is currently 21.76%.

Wall Street Analyst Weigh In

Separately, Zacks Research cut Novozymes A/S from a “strong-buy” rating to a “hold” rating in a report on Monday, August 25th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.